Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Objective: Glucocorticoid (GC) therapy is associated with adverse effects on bone metabolism, yet the effects of different GC physiological replacement regimens in hypopituitarism are not well characterised. We aimed to assess the effect of three hydrocortisone (HC) replacement dose regimens on bone turnover. Study design: An open cross-over study randomising ten hypopituitary men with severe ACTH deficiency to three commonly used HC dose regimens: dose A (20 mg mane and 10 mg tarde), dose B (10 mg mane and 10 mg tarde) and dose C (10 mg mane and 5 mg tarde). Methods: Following 6 weeks of each regimen, the participants underwent 24-h serum cortisol sampling and measurement of bone turnover markers: bone-specific alkaline phosphatase, procollagen type I N-propeptide (PINP), intact osteocalcin (OC(1–49)), C-terminal cross-linking telopeptide (CTX-I) and tartrate-resistant acid phosphatase 5b (TRACP5b). Bone remodelling balance was estimated as an absolute ratio (PINP:CTX-I) and as an index using standardised scores derived from the matched controls. Results: There were significant increases in the concentrations of the formation markers PINP (P=0.045) and OC(1–49) (P=0.006) and in the PINP:CTX-I ratio (P=0.015), and a more positive bone remodelling balance index (P=0.03) was observed in patients on the lowest dose C than in those on the highest dose A. Mean 24-h cortisol concentrations correlated negatively with CTX-I (r=−0.66 and P=0.04) and TRACP5b (r=−0.74 and P=0.01) in patients on dose B and with OC(1–49) (r=−0.66 and P=0.04) and CTX-I (r=−0.81 and P<0.01) in patients on dose C. In patients receiving the lower-dose regimen, trough cortisol concentrations correlated with increased bone formation and resorption. Conclusion: Low-dose HC replacement (10 mg mane and 5 mg tarde) is associated with increased bone formation and a positive bone remodelling balance. This may have a long-term beneficial effect on bone health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a randomized crossover study (205), peripheral and hepatic insulin resistance did not differ between patients treated with HC twice daily (15 mg with breakfast, 5 mg with evening meal) versus those receiving physiological HC infusions.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [205]
Citations
Cites
Use of Inhaled Corticosteroids and Risk of Fractures
Van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,308
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
Staa, T. P. V., Geusens, P., Bijlsma, J. W. J., Leufkens, H. G. M., & Cooper, C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22117 · Cited by 587
Biochemical markers of bone turnover: part I: biochemistry and variability.
Seibel, M. J. (2005) · Europe PMC (PubMed Central) · Cited by 584
Qvist, P., Christgau, S., Pedersen, B. J., Schlemmer, A., & Christiansen, C. (2002) · Bone · doi:10.1016/s8756-3282(02)00791-3 · Cited by 348
Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321
The degree of mineralization is a determinant of bone strength: a study on human calcanei
Follet, H., Boivin, G., Rumelhart, C., & Meunier, P. J. (2004) · Bone · doi:10.1016/j.bone.2003.12.012 · Cited by 269
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Luengo, M., Picado, C., Del Rio, L., Guanabens, N., Montserrat, J. M., & Setoain, J. (1991) · Thorax · doi:10.1136/thx.46.11.803 · Cited by 241
Zelissen, P. M. J., Croughs, R. J. M., van Rijk, P. P., & Raymakers, J. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00005 · Cited by 225
Research works printed but not linked: 4
- McDougall, 1994, The Journal of Rheumatology, 21, 1207
- 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 20, 1487
- Verrotti, 2000, Annals of neurology, 47, 385, 10.1002/1531-8249(200003)47:3<385::aid-ana18>3.0.co;2-w · doi:10.1002/1531-8249(200003)47:3<385::aid-ana18>3.0.co;2-w
- 2005, CLINICAL BIOCHEMIST REVIEWS, 26, 97
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
CircRNA–miRNA networks in regulating bone disease
Huang, W., Wu, Y., Qiao, M., Xie, Z., Cen, X. B., Huang, X., & Zhao, Z. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30625 · Cited by 57
“Also, glucocorticoid functions differently depending on its dose, bone impairment will only occur when using an excess dose of glucocorticoid while a physiological dose of glucocorticoid has a protecting role of bone instead (Behan et al., 2014).”
BackgroundCamozzi, V., Betterle, C., Frigo, A. C., Zaccariotto, V., Zaninotto, M., Caneva, E. D., Lucato, P., Gomiero, W., Garelli, S., Sabbadin, C., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1380-8 · Cited by 39
“found that the lower dose of hydrocortisone replacement that they used was actually associated with an increased bone formation and a positive bone remodeling balance [41].”
BackgroundBehan, L.-A., Carmody, D., Rogers, B., Hannon, M. J., Davenport, C., Tormey, W., Smith, D., Thompson, C. J., Stanton, A., & Agha, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1187 · Cited by 28
Self-citationDaily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review
Caetano, C. M., & Malchoff, C. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.897211 · Cited by 29
Metadata
- Authors
- Behan, L.-A., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Tormey, W., Smith, D., Thompson, C. J., McKenna, M. J., & Agha, A.
- Affiliations
- Beaumont Hospital (IE)
- St. Vincent's University Hospital (IE)
- University College Dublin (IE)
- Corresponding author
- Agha, Amar
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01
- Volume
- 170
- Issue
- 1
- Pages
- 141-150
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2142225547
- Cited by
- 23
- References
- 36
- Citations by year
- 2026: 1 · 2024: 3 · 2022: 3 · 2021: 3 · 2020: 3 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 1
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Royal College of Surgeons in Ireland
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- hydrocortisone replacement, hypopituitarism, ACTH deficiency, bone turnover markers, bone formation, bone resorption, bone-specific alkaline phosphatase, P1NP, osteocalcin, C-terminal telopeptide of type I collagen, TRACP-5b, male patients, bone health
- MeSH terms
- Adrenal Insufficiency, Adult, Bone and Bones, Bone Resorption, Dose-Response Relationship, Drug, Glucocorticoids, Humans, Hydrocortisone, Hypopituitarism, Male, Middle Aged, Osteogenesis, Severity of Illness Index, Cohort Studies, Biomarkers, Bone Remodeling, Cross-Over Studies, Hormone Replacement Therapy, Bone Density Conservation Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients. https://app.cochat.ai/papers/10.1530/eje-13-0596
- The paper
- Behan, L.-A., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Tormey, W., Smith, D., Thompson, C. J., McKenna, M. J., & Agha, A. (2014). Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients. European Journal of Endocrinology. https://doi.org/10.1530/eje-13-0596
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.